<?xml version='1.0' encoding='UTF-8'?>
<search_results><query id="7173"> severed spinal cord</query><engine status="OK" timestamp="2014-04-21 08:56:10" name="The Street" id="FW14-e108"/><snippets><snippet id="FW14-e108-7173-01"><link cache="FW14-topics-docs/e108/7173_01.html" timestamp="2014-04-21 08:56:11">http://www.thestreet.com/find/results/index.html?q=%20severed%20spinal%20cord&amp;omorig=header</link><title>EC launches in-depth probe of J&amp;J's Synthes takeover</title><description>EC launches in-depth probe of J&amp;J's Synthes takeover

By Renee Cordes 08:57 AM EDT 11/04/11</description></snippet><snippet id="FW14-e108-7173-02"><link cache="FW14-topics-docs/e108/7173_02.html" timestamp="2014-04-21 08:56:49">http://www.thestreet.com/find/results/index.html?q=%20severed%20spinal%20cord&amp;omorig=header</link><title>EC launches in-depth probe of J&amp;J's Synthes takeover</title><description>EC launches in-depth probe of J&amp;J's Synthes takeover

By Renee Cordes 05:39 AM EDT 11/04/11</description></snippet><snippet id="FW14-e108-7173-03"><link cache="FW14-topics-docs/e108/7173_03.html" timestamp="2014-04-21 08:58:55">http://www.thestreet.com/story/10470613/1/geron-stem-cell-trial-risky-doctors-warn.html</link><title>Geron Stem Cell Trial Risky, Doctors Warn</title><description>Geron Stem Cell Trial Risky, Doctors Warn

By Adam Feuerstein 11:59 AM EDT 03/11/09

Some doctors criticize an upcoming study of regenerative stem cell therapy in spinal cord patients.

http://www.thestreet.com/story/10470613/1/geron-stem-cell-trial-risky-doctors-warn.html</description></snippet><snippet id="FW14-e108-7173-04"><link cache="FW14-topics-docs/e108/7173_04.html" timestamp="2014-04-21 09:01:21">http://www.thestreet.com/story/10608802/1/targacept-unveils-depression-drug-data-next-week-biobuzz.html</link><title>Targacept Unveils Depression Drug Data Next Week: BioBuzz</title><description>Targacept Unveils Depression Drug Data Next Week: BioBuzz

By Adam Feuerstein 08:46 AM EDT 10/08/09

Stock price rises going into Oct. 15 presentation of TC-5214 data.

http://www.thestreet.com/story/10608802/1/targacept-unveils-depression-drug-data-next-week-biobuzz.html</description></snippet><snippet id="FW14-e108-7173-05"><link cache="FW14-topics-docs/e108/7173_05.html" timestamp="2014-04-21 09:03:55">http://www.thestreet.com/story/10167163/1/new-medtronic-pump-wins-approval.html</link><title>New Medtronic Pump Wins Approval</title><description>New Medtronic Pump Wins Approval

By Eric Gillin 09:29 AM EDT 06/22/04

The FDA signs off on the company's second-generation implantable medicine pump.

http://www.thestreet.com/story/10167163/1/new-medtronic-pump-wins-approval.html</description></snippet><snippet id="FW14-e108-7173-06"><link cache="FW14-topics-docs/e108/7173_06.html" timestamp="2014-04-21 09:04:58">http://www.thestreet.com/story/10609175/1/hemispherx-ceo-spills-ampligen-beans-to-stock-cheerleader-biobuzz.html</link><title>Hemispherx CEO Spills Ampligen Beans to Stock Cheerleader: BioBuzz</title><description>Hemispherx CEO Spills Ampligen Beans to Stock Cheerleader: BioBuzz

By Adam Feuerstein 03:31 PM EDT 10/08/09

'Important news' on Ampligen and FDA to be released by stock promoter Friday.

http://www.thestreet.com/story/10609175/1/hemispherx-ceo-spills-ampligen-beans-to-stock-cheerleader-biobuzz.html</description></snippet><snippet id="FW14-e108-7173-07"><link cache="FW14-topics-docs/e108/7173_07.html" timestamp="2014-04-21 09:05:50">http://www.thestreet.com/story/10354143/1/teva-moves-ahead-on-ms-pill.html</link><title>Teva Moves Ahead on MS Pill</title><description>Teva Moves Ahead on MS Pill

By Robert Steyer 05:06 PM EDT 05/01/07

The drugmaker plans an advanced clinical trial for laquinimod.

http://www.thestreet.com/story/10354143/1/teva-moves-ahead-on-ms-pill.html</description></snippet><snippet id="FW14-e108-7173-08"><link cache="FW14-topics-docs/e108/7173_08.html" timestamp="2014-04-21 09:09:49">http://www.thestreet.com/story/10412010/1/dnas-rituxan-flunks-ms-trial.html</link><title>DNA's Rituxan Flunks MS Trial</title><description>DNA's Rituxan Flunks MS Trial

By Adam Feuerstein 10:04 AM EDT 04/15/08

Genentech and Biogen Idec hoped to expand the drug into the intractable form of multiple sclerosis.

http://www.thestreet.com/story/10412010/1/dnas-rituxan-flunks-ms-trial.html</description></snippet><snippet id="FW14-e108-7173-09"><link>http://www.thestreet.com/rmoney/biotech/11176925.html</link><title>Investors in Accord with Acorda RealMoney ($)</title><description>Investors in Accord with Acorda RealMoney ($)

By Ken Shreve 09:15 AM EDT 07/07/11

Recent price and volume trends have been solid.

/rmoney/biotech/11176925.html</description></snippet><snippet id="FW14-e108-7173-10"><link cache="FW14-topics-docs/e108/7173_10.html" timestamp="2014-04-21 09:16:10">http://www.thestreet.com/story/10761836/1/novabay-pharmaceuticals-ceo-interview.html</link><title>NovaBay Pharmaceuticals: CEO Interview</title><description>NovaBay Pharmaceuticals: CEO Interview

By Robert Holmes 06:01 AM EDT 05/20/10

NovaBay Chairman and CEO Ron Najafi speaks about recent clinical trial data and the small-cap biotech company's future.

http://www.thestreet.com/story/10761836/1/novabay-pharmaceuticals-ceo-interview.html</description></snippet></snippets></search_results>